Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

The following Interfaces are supported For financial accounting, the following interfaces provided as RESTful-API show results for deal 001-FK_LN–Consumer-Annuity). To expand please click on the specific line.

...

GET /loans/risk-ratios (001-FK_LN-A-Consumer-Annuity

30638.2986206445

30638.2986206445

29624.3420623926

29624.3420623926

29805.4831928161

29805.4831928161

28039.7556081428

28039.7556081428

28104.6661257326

28104.6661257326

-210.79
Expand
titleGET /loans/accounting-transaction-related-accounting-ratios (001-FK_LN-A-Consumer-Annuity)

The following table shows for a

  • specific tenant (companyId) and for
  • deal (dealId) "001-FK_LN-A-Consumer-Annuity" and for 
  • GAAP (gaap) "IFRS"

accounting transactions at various posting dates (postingDate)

For the explanation of the data fields see here.



postingDate accountingTransactionmeasureOrRatioDescriptionsignOfMeasureOrRatioamountAccountingRatiocurrencyTransactionamountAccountingRatioBalbankClientcustomerTypeproductaccountingCategoryimpairmentStageimpairmentType
13/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-247.45EUR247.450Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
13/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-247.45EUR247.450Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Capital Payout ContractualCapital amount-0EUR00Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Capital Payout ContractualCapital amount-0EUR00Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Capital Payout ContractualCapital amount-33000EUR330000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Capital Payout ContractualCapital amount-33000EUR330000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Capital Payout Real PaymentCapital amount-33000EUR330000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Capital Payout Real PaymentCapital amount-33000EUR330000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+247.45EUR247.450Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+247.45EUR247.450Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-247.5EUR247.50Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-247.5EUR247.50Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-1.76EUR1.760Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-1.76EUR1.760Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+112.93EUR112.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+112.93EUR112.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+247.5EUR247.50Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+247.5EUR247.50Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-248.33EUR248.330Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-248.33EUR248.330Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-1.76EUR1.760Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-1.76EUR1.760Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+112.93EUR112.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+112.93EUR112.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+175.9EUR175.90Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+175.9EUR175.90Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.96EUR2.960Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.96EUR2.960Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Real RepaymentCapital amount+812.8EUR812.80Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Real RepaymentCapital amount+812.8EUR812.80Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Real RepaymentCapital amount+820.91EUR820.910Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Real RepaymentCapital amount+820.91EUR820.910Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Real RepaymentCapital amount+906.85EUR906.850Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Real RepaymentCapital amount+906.85EUR906.850Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Repayment ContractualCapital amount+812.8EUR812.80Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Repayment ContractualCapital amount+812.8EUR812.80Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Repayment ContractualCapital amount+820.91EUR820.910Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Repayment ContractualCapital amount+820.91EUR820.910Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Repayment ContractualCapital amount+906.85EUR906.850Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Repayment ContractualCapital amount+906.85EUR906.850Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-229.79EUR229.790Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-229.79EUR229.790Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+248.33EUR248.330Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+248.33EUR248.330Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears ContractualCapital amount+119.99EUR119.990Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears ContractualCapital amount+119.99EUR119.990Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears ContractualCapital amount+205.93EUR205.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears ContractualCapital amount+205.93EUR205.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears ContractualCapital amount+214.04EUR214.040Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears ContractualCapital amount+214.04EUR214.040Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears Real PaymentsCapital amount+119.99EUR119.990Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears Real PaymentsCapital amount+119.99EUR119.990Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears Real PaymentsCapital amount+205.93EUR205.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears Real PaymentsCapital amount+205.93EUR205.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears Real PaymentsCapital amount+214.04EUR214.040Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears Real PaymentsCapital amount+214.04EUR214.040Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+175.9EUR175.90Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+175.9EUR175.90Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.81EUR2.810Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.81EUR2.810Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.96EUR2.960Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.96EUR2.960Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Capital Real RepaymentCapital amount+837.91EUR837.910Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Capital Real RepaymentCapital amount+837.91EUR837.910Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Capital Repayment ContractualCapital amount+837.91EUR837.910Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Capital Repayment ContractualCapital amount+837.91EUR837.910Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-222.18EUR222.180Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-222.18EUR222.180Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+229.79EUR229.790Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+229.79EUR229.790Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Incoming Interest in Arrears ContractualCapital amount+188.93EUR188.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Incoming Interest in Arrears ContractualCapital amount+188.93EUR188.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Incoming Interest in Arrears Real PaymentsCapital amount+188.93EUR188.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Incoming Interest in Arrears Real PaymentsCapital amount+188.93EUR188.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+177.4EUR177.40Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+177.4EUR177.40Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.81EUR2.810Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.81EUR2.810Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+6.55EUR6.550Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+6.55EUR6.550Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+222.18EUR222.180Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+222.18EUR222.180Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-223.54EUR223.540Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-223.54EUR223.540Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-10.02EUR10.020Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-10.02EUR10.020Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+113.53EUR113.530Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+113.53EUR113.530Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+177.4EUR177.40Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+177.4EUR177.40Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+6.55EUR6.550Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+6.55EUR6.550Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Capital Real RepaymentCapital amount+842.18EUR842.180Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Capital Real RepaymentCapital amount+842.18EUR842.180Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Capital Real RepaymentCapital amount+843.1EUR843.10Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Capital Real RepaymentCapital amount+843.1EUR843.10Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Capital Repayment ContractualCapital amount+842.18EUR842.180Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Capital Repayment ContractualCapital amount+842.18EUR842.180Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Capital Repayment ContractualCapital amount+843.1EUR843.10Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Capital Repayment ContractualCapital amount+843.1EUR843.10Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-210.3EUR210.30Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-210.3EUR210.30Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+223.54EUR223.540Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+223.54EUR223.540Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Incoming Interest in Arrears ContractualCapital amount+183.74EUR183.740Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Incoming Interest in Arrears ContractualCapital amount+183.74EUR183.740Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Incoming Interest in Arrears ContractualCapital amount+184.66EUR184.660Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Incoming Interest in Arrears ContractualCapital amount+184.66EUR184.660Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Incoming Interest in Arrears Real PaymentsCapital amount+183.74EUR183.740Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Incoming Interest in Arrears Real PaymentsCapital amount+183.74EUR183.740Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Incoming Interest in Arrears Real PaymentsCapital amount+184.66EUR184.660Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Incoming Interest in Arrears Real PaymentsCapital amount+184.66EUR184.660Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-10.02EUR10.020Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-10.02EUR10.020Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+113.53EUR113.530Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+113.53EUR113.530Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+173.28EUR173.280Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+173.28EUR173.280Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-4.87EUR4.870Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-4.87EUR4.870Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+210.3EUR210.30Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+210.3EUR210.30Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-210.79EUR210.790Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-210.79EUR210.790Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
Expand
title
)

The following table shows risk ratios for deal "001-FK_LN-A-Consumer-Annuity" at different posting dates. 

For the explanation of the data fields see here.

postingDate companyIddealIdgaapcurrencyDealmacroeconomicScenario rwapdlgdeadprobWeightedEcl
14/09/20181001-FK_LN-A-Consumer-AnnuityIFRS9EURBASELINE SCENARIO STD023033000.0000000205-247.5
14/09/20181001-FK_LN-A-Consumer-AnnuityIFRS9EURADVERSE SCENARIO STD034033000.0000000205-247.5
30/09/20181001-FK_LN-A-Consumer-AnnuityIFRS9EURBASELINE SCENARIO STD023033111.1758407037-248.33
30/09/20181001-FK_LN-A-Consumer-AnnuityIFRS9EURADVERSE SCENARIO STD034033111.1758407037-248.33
31/12/20181001-FK_LN-A-Consumer-AnnuityIFRS9EURBASELINE SCENARIO STD0230-229.7931/12/20181001-FK_LN-A-Consumer-AnnuityIFRS9EURADVERSE SCENARIO STD0340-229.7902/01/20191001-FK_LN-A-Consumer-AnnuityIFRS9EURBASELINE SCENARIO STD0230-222.1802/01/20191001-FK_LN-A-Consumer-AnnuityIFRS9EURADVERSE SCENARIO STD0340-222.1831/01/20191001-FK_LN-A-Consumer-AnnuityIFRS9EURBASELINE SCENARIO STD0230-223.5431/01/20191001-FK_LN-A-Consumer-AnnuityIFRS9EURADVERSE SCENARIO STD0340-223.5420/03/20191001-FK_LN-A-Consumer-AnnuityIFRS9EURBASELINE SCENARIO STD0230-210.320/03/20191001-FK_LN-A-Consumer-AnnuityIFRS9EURADVERSE SCENARIO STD0340-210.331/03/20191001-FK_LN-A-Consumer-AnnuityIFRS9EURBASELINE SCENARIO STD0230-210.7931/03/20191001-FK_LN-A-Consumer-AnnuityIFRS9EURADVERSE SCENARIO STD0340